Cortexyme () EPS US GAAP (year values) |
|||||||||
| 2017 | 2018 | 2019 | 2020 | 2021 | LTM ? | CAGR 5 years ? | |||
| EPS, rub | ? | -0.57 | -0.58 | -1.94 | -2.63 | -3.02 | 0.00 | ||
| Changes by years, y/y, % | +2% | +235% | +36% | +15% | +51.9% | ||||
Cortexyme. EPS, rub
Cortexyme. EPS, changes, %
Cortexyme () EPS US GAAP (quarter values) |
||||||||
| 2021Q2 | 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | LTM ? | |||
| EPS, rub | ? | -0.74 | -0.73 | -3.02 | -0.72 | 0.00 | 0.00 | |
| Changes by years, y/y, % | +23% | 0% | +333% | -8% | -100% | |||
| Changes by quarters, q/q, % | -6% | -1% | +314% | -76% | -100% | |||